Cystic fibrosis secondary prevention: Difference between revisions
Jump to navigation
Jump to search
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
In cystic fibrosis secondary prevention include airway clearance techniques, dornase alpha, hypertonic saline, antibiotics, immunizations, physical activity, nutritional support for pancreatic insufficiency and extra salt and water. | In cystic fibrosis secondary prevention include [[airway]] clearance techniques, [[Dornase alfa|dornase alpha]], [[hypertonic]] [[Saline (medicine)|saline]], [[Antibiotic|antibiotics]], [[Vaccination|immunizations]], [[Physical exercise|physical activity]], nutritional support for [[pancreatic insufficiency]] and extra salt and water. | ||
==Secondary Prevention== | ==Secondary Prevention== | ||
In cystic fibrosis secondary prevention include:<ref name="pmid29303286">{{cite journal |vauthors=Fila L |title=[Cystic fibrosis in adults] |language=Czech |journal=Vnitr Lek |volume=63 |issue=11 |pages=834–842 |date= 2018 |pmid=29303286 |doi= |url=}}</ref><ref name="urlCystic Fibrosis and Congenital Absence of the Vas Deferens - GeneReviews® - NCBI Bookshelf">{{cite web |url=https://www.ncbi.nlm.nih.gov/books/NBK1250/ |title=Cystic Fibrosis and Congenital Absence of the Vas Deferens - GeneReviews® - NCBI Bookshelf |format= |work= |accessdate=}}</ref> | In cystic fibrosis secondary prevention include:<ref name="pmid29303286">{{cite journal |vauthors=Fila L |title=[Cystic fibrosis in adults] |language=Czech |journal=Vnitr Lek |volume=63 |issue=11 |pages=834–842 |date= 2018 |pmid=29303286 |doi= |url=}}</ref><ref name="urlCystic Fibrosis and Congenital Absence of the Vas Deferens - GeneReviews® - NCBI Bookshelf">{{cite web |url=https://www.ncbi.nlm.nih.gov/books/NBK1250/ |title=Cystic Fibrosis and Congenital Absence of the Vas Deferens - GeneReviews® - NCBI Bookshelf |format= |work= |accessdate=}}</ref> | ||
* Airway clearance techniques | * [[Airway]] clearance techniques | ||
* Dornase alpha | * [[Dornase alfa|Dornase alpha]] | ||
* Hypertonic saline | * [[Hypertonic]] [[Saline (medicine)|saline]] | ||
* Antibiotics for prevention of airway [[infection]] with resistant bacterial pathogens (especially ''[[Pseudomonas aeruginosa|P. aeruginosa]]'') | * [[Antibiotic|Antibiotics]] for prevention of [[airway]] [[infection]] with resistant [[Bacteria|bacterial]] [[Pathogen|pathogens]] (especially ''[[Pseudomonas aeruginosa|P. aeruginosa]]'') | ||
* Immunizations including anti-RSV monoclonal antibody | * [[Vaccination|Immunizations]] including anti-RSV [[Monoclonal antibodies|monoclonal antibody]] | ||
* Physical activity to maintain bone health and improve airway clearance | * [[Physical exercise|Physical activity]] to maintain bone health and improve [[airway]] clearance | ||
* Nutritional support for pancreatic insufficiency | * Nutritional support for [[pancreatic insufficiency]] | ||
* Extra salt and water | * Extra salt and water | ||
* Hot and dry climates | * Hot and dry climates |
Revision as of 19:09, 9 March 2018
Cystic fibrosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Cystic fibrosis secondary prevention On the Web |
American Roentgen Ray Society Images of Cystic fibrosis secondary prevention |
Risk calculators and risk factors for Cystic fibrosis secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shaghayegh Habibi, M.D.[2]
Overview
In cystic fibrosis secondary prevention include airway clearance techniques, dornase alpha, hypertonic saline, antibiotics, immunizations, physical activity, nutritional support for pancreatic insufficiency and extra salt and water.
Secondary Prevention
In cystic fibrosis secondary prevention include:[1][2]
- Airway clearance techniques
- Dornase alpha
- Hypertonic saline
- Antibiotics for prevention of airway infection with resistant bacterial pathogens (especially P. aeruginosa)
- Immunizations including anti-RSV monoclonal antibody
- Physical activity to maintain bone health and improve airway clearance
- Nutritional support for pancreatic insufficiency
- Extra salt and water
- Hot and dry climates
References
- ↑ Fila L (2018). "[Cystic fibrosis in adults]". Vnitr Lek (in Czech). 63 (11): 834–842. PMID 29303286.
- ↑ "Cystic Fibrosis and Congenital Absence of the Vas Deferens - GeneReviews® - NCBI Bookshelf".